Serialization - New service offer from Med-X-Press

At Med-X-Press, the entire serialization system is controlled from a single computer

The EU security system for prescription medicines was launched on 9 February 2019, accompanied by many discussions: the deadline for implementing the EU Anti-Counterfeiting Directive. The pharmaceutical logistics company Med-X-Press was well prepared and offers pharmaceutical manufacturers company-specific offers for printing the product code and affixing the tamper-evident seal.

At the pharmaceutical logistics company Med-X-Press in Goslar, working groups and project groups were formed at an early stage to develop serialization concepts specifically tailored to the needs of customers. The result is a comprehensive offer for the printing of folding boxes of prescription drugs in connection with the application of a tamper-proof tamper-evident closure. These measures are intended to ensure complete traceability of the product and to ensure that a drug has not been opened or manipulated without authorisation prior to delivery to the patient. Both ensure a high level of protection for patients against counterfeit medicines in the legal supply chain of medicines. Med-X-Press has conducted many discussions with pharmaceutical manufacturers to identify the requirements of manufacturers and implement them in an offer suitable for potential customers.  The logistics provider has invested in a system at the Goslar site that prints and verifies the prescribed code for identifying the drug.  In the same process, the package is sealed with the tamper-evident seal.

In order to meet current customer requirements, Med-X-Press has decided to invest in a further line. Soon it will also be possible to print unfilled folding boxes with the serialization code.

These services, which are of particular interest for smaller batches, are provided by Med-X-Press within the scope of its manufacturing license according to §13.1 of the German Medicines Act (AMG). In addition to this outsourcing offer for pharmaceutical manufacturers, the officially GDP-certified pharmaceutical logistician realizes the measures specified by the EU directive within the scope of his wholesale permit according to §52.a AMG. The measures include checks on incoming goods as well as on returns and their derecognition from the European security system.